Announcing Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong
Read UMR's Statement on the House Appropriations Committee's Passage of FY23 Labor-HHS Funding Bill
NIH's Role In Sustaining the U.S. Economy | 2022 Update Now Available

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Behind Covid-19 vaccine development

A machine learning model developed jointly by Janssen and MIT data scientists played a key role in the clinical trial process for the Johnson & Johnson Covid-19 vaccine

When starting a vaccine program, scientists generally have anecdotal understanding of the disease they’re aiming to target. When Covid-19 surfaced over a year ago, there were so many unknowns about the fast-moving virus that scientists had to act quickly and rely on new methods and techniques just to even begin understanding the basics of the disease. Scientists at Janssen Research & Development, developers of the Johnson & Johnson Covid-19 vaccine, leveraged real-world data and, working with MIT researchers, applied artificial intelligence and machine learning to help guide the company’s research efforts into a potential vaccine.